# Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV)

> **NCT01276756** · PHASE2,PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 100 (actual)

## Conditions studied

- Chronic Hepatitis c

## Interventions

- **DRUG:** Pegylated interferon alfa-2a
- **DRUG:** Nitazoxanide
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT01276756
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2013-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01276756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01276756, "Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01276756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*